export const questions = [
  {
    question: "What is the histopathologic appearance of bone in Osteogenesis Imperfecta?",
    options: ["Thick cortex with dense trabeculation", "Thin cortex, fine trabeculation, and diffuse osteoporosis", "Normal bone architecture", "Sclerotic bone with no marrow spaces"],
    answer: 1
  },
  {
    question: "In which type of Osteogenesis Imperfecta do the sclera remain distinctly blue at all ages?",
    options: ["Type I", "Type II", "Type III", "Type IV"],
    answer: 0
  },
  {
    question: "What is a common orthodontic finding in Osteogenesis Imperfecta patients?",
    options: ["Class III malocclusion due to maxillary hypoplasia", "Class II malocclusion due to mandibular retrognathia", "Open bite", "Crossbite"],
    answer: 0
  },
  {
    question: "Why is the use of dental implants questionable in Osteogenesis Imperfecta patients with dental involvement?",
    options: ["Poor oral hygiene", "Deficient quality of the supporting bone", "Allergy to titanium", "High cost"],
    answer: 1
  },
  {
    question: "What is the radiographic distinction in Osteopetrosis?",
    options: ["Increased distinction between cortical and cancellous bone", "Loss of distinction between cortical and cancellous bone", "Thinning of cortical bone", "Cystic changes in bone"],
    answer: 1
  },
  {
    question: "What cranial nerve complication is common in Infantile Osteopetrosis?",
    options: ["Optic nerve atrophy and blindness", "Trigeminal neuralgia", "Facial nerve palsy only", "Glossopharyngeal nerve paralysis"],
    answer: 0
  },
  {
    question: "Which osteopetrosis pattern is inherited as an autosomal dominant trait?",
    options: ["Infantile osteopetrosis", "Malignant osteopetrosis", "Adult osteopetrosis", "Intermediate osteopetrosis"],
    answer: 2
  },
  {
    question: "What is the function of the CBFA1 gene mutated in Cleidocranial Dysplasia?",
    options: ["Guides osteoblastic differentiation and bone formation", "Codes for type I collagen", "Regulates osteoclast activity", "Controls vitamin D metabolism"],
    answer: 0
  },
  {
    question: "What percentage of Cleidocranial Dysplasia cases appear to represent spontaneous mutations?",
    options: ["10%", "20%", "40%", "60%"],
    answer: 2
  },
  {
    question: "What is the treatment for the skull and clavicular anomalies in Cleidocranial Dysplasia?",
    options: ["Surgical correction", "No treatment exists; most patients function well", "Radiotherapy", "Chemotherapy"],
    answer: 1
  },
  {
    question: "The Focal Osteoporotic Marrow Defect is typically:",
    options: ["Symptomatic and painful", "Asymptomatic and discovered incidentally", "Associated with swelling", "Causes tooth mobility"],
    answer: 1
  },
  {
    question: "What is the prognosis for a Focal Osteoporotic Marrow Defect after diagnosis?",
    options: ["Poor, requires extensive surgery", "Excellent, no further treatment needed", "Guarded, frequent monitoring required", "Depends on the patient's age"],
    answer: 1
  },
  {
    question: "What is the proposed role of RANKL in Paget's disease?",
    options: ["Inhibits osteoclastogenesis", "Stimulates osteoblast apoptosis", "Causes hyperresponsiveness of osteoclast precursors", "Promotes enamel formation"],
    answer: 2
  },
  {
    question: "In early stages, Paget's disease radiographically exhibits:",
    options: ["Increased radiodensity", "Decreased radiodensity and coarse trabeculae", "No change in bone appearance", "Moth-eaten appearance"],
    answer: 1
  },
  {
    question: "For which Paget's disease patients is systemic therapy usually initiated?",
    options: ["All patients regardless of symptoms", "Only patients with bone pain", "Asymptomatic patients with alkaline phosphatase >25-50% above normal", "Patients under 40 years old"],
    answer: 2
  }
];